Toshimitsu Yamaoka
14PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Oct 29, 2025
Recent Advances in the Development and Clinical Use of HER2 Inhibitors in Non-Small Cell Lung Cancer.Richy Ekyalongo, Toshimitsu Yamaoka, Junji Tsurutani
|Feb 11, 2023
Comparative Efficacy of ALK Inhibitors for Treatment-Naïve ALK-Positive Advanced Non-Small Cell Lung Cancer with Central Nervous System Metastasis: A Network Meta-Analysis.Koichi Ando, Ryo Manabe, Yasunari Kishino
|Dec 23, 2022
Mechanisms of EGFR-TKI-Induced Apoptosis and Strategies Targeting Apoptosis in EGFR-Mutated Non-Small Cell Lung Cancer.Shigetoshi Nishihara, Toshimitsu Yamaoka, Fumihiro Ishikawa
|Jul 27, 2022
Diverse Mechanisms of Resistance against Osimertinib, a Third-Generation EGFR-TKI, in Lung Adenocarcinoma Cells with an EGFR-Activating Mutation.Shigetoshi Nishihara, Toshimitsu Yamaoka, Fumihiro Ishikawa
|Aug 07, 2021
Comparative Efficacy and Safety of Lorlatinib and Alectinib for ALK-Rearrangement Positive Advanced Non-Small Cell Lung Cancer in Asian and Non-Asian Patients: A Systematic Review and Network Meta-Analysis.Koichi Ando, Ryo Manabe, Yasunari Kishino
|Mar 06, 2021
Comparative Efficacy and Safety of Immunotherapeutic Regimens with PD-1/PD-L1 Inhibitors for Previously Untreated Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis.Koichi Ando, Ryo Manabe, Yasunari Kishino
Pageof 3
